Clinical Trial Detail

NCT ID NCT02600949
Title Peptide Vaccine in Advanced Pancreatic Ductal Adenocarcinoma or Colorectal Adenocarcinoma
Recruitment Active, not recruiting
Gender
Phase Phase I
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

pancreatic ductal adenocarcinoma

colorectal cancer

Therapies

Pembrolizumab

Age Groups:

No variant requirements are available.